Bar Harbor Wealth Management Trims Position in iShares Biotechnology ETF (NASDAQ:IBB)

Bar Harbor Wealth Management trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 14,826 shares of the financial services provider’s stock after selling 491 shares during the quarter. Bar Harbor Wealth Management’s holdings in iShares Biotechnology ETF were worth $2,159,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. BNP Paribas Financial Markets lifted its position in iShares Biotechnology ETF by 25.7% in the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the period. Main Management ETF Advisors LLC increased its holdings in iShares Biotechnology ETF by 2.6% in the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after buying an additional 14,535 shares in the last quarter. Global Assets Advisory LLC purchased a new position in iShares Biotechnology ETF in the first quarter valued at about $66,059,000. Raymond James Financial Services Advisors Inc. increased its holdings in iShares Biotechnology ETF by 24.6% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after buying an additional 42,822 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its holdings in iShares Biotechnology ETF by 5.3% in the first quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock valued at $27,267,000 after buying an additional 10,033 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.5 %

Shares of iShares Biotechnology ETF stock opened at $145.69 on Friday. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57. The company has a 50-day moving average of $145.57 and a two-hundred day moving average of $139.59.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.